TIMP3 and colorectal carcinoma: We next identified TIMP3 as the downstream target of miR‐937‐5p in both CRC cells and tissue samples and discovered that miR‐937‐5p, which acted as an oncogene in CRC, inhibited TIMP3 activity by direct downregulation of its expression.